WAVE Life Sciences Ltd.
WVE
$13.02
-$0.33-2.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 126.67% | -12.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 126.67% | -12.54% | |||
| Cost of Revenue | 15.13% | 5.53% | |||
| Gross Profit | 7.05% | -10.05% | |||
| SG&A Expenses | 15.54% | 0.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.25% | 4.07% | |||
| Operating Income | -0.20% | -6.81% | |||
| Income Before Tax | 1.25% | -6.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.25% | -6.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.25% | -6.70% | |||
| EBIT | -0.20% | -6.81% | |||
| EBITDA | -0.23% | -6.94% | |||
| EPS Basic | 8.10% | -4.29% | |||
| Normalized Basic EPS | 8.12% | -4.31% | |||
| EPS Diluted | 8.10% | -4.29% | |||
| Normalized Diluted EPS | 8.12% | -4.31% | |||
| Average Basic Shares Outstanding | 7.48% | 2.29% | |||
| Average Diluted Shares Outstanding | 7.48% | 2.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||